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Variation on a Theme of SDR: dTDP-6-Deoxy-L-
lyxo-4-Hexulose Reductase (RmlD) Shows a New
Mg2-Dependent Dimerization Mode
making newly approved drugs useless within only a few
years. There is thus a permanent need for the develop-
ment of novel antibiotics, either through the variation of
known principles or through targeting pathways so far
unexploited.
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part but also has a vital shielding function, and its com-United Kingdom
2 Joint Structural Biology Group ponents are often important virulence factors. Among
the main components of the bacterial cell wall are com-ESRF
F38043 Grenoble Cedex plex carbohydrate structures. One of the building blocks
in a wide variety of both Gram-positive and Gram-nega-France
3 Department of Microbiology tive species is L-rhamnose, a 6-deoxyhexose that is not
present in mammals. L-rhamnose has been found toUniversity of Guelph
Ontario N1G 2W1 occupy important anchoring positions, e.g., in Mycobac-
terium tuberculosis, where it covalently links the arabi-Canada
4 Zentrum fu¨r Ultrastrukturforschung und nogalactan to the peptidoglycan layer [1]. It has been
demonstrated that loss of arabinogalactan leads to lossLudwig Boltzmann-Institut fu¨r Molekulare
Nanotechnologie of viability of this important pathogen [2, 3]. In a recent
study, inhibitors of L-rhamnose-synthesizing enzymesUniversita¨t fu¨r Bodenkultur Wien
A-1180 Vienna were shown to possess activity against whole M. tuber-
culosis cells [4]. Gram-negative bacteria utilize L-rham-Austria
nose in their lipopolysaccharide (LPS). For example, the
opportunistic pathogen Pseudomonas aeruginosa in-
corporates L-rhamnose both in the O-antigens of vari-Summary
ous serotypes and in the common core polysaccharide
of LPS of all strains. Mutants with impaired LPS synthe-dTDP-6-deoxy-L-lyxo-4-hexulose reductase (RmlD)
catalyzes the final step in the conversion of dTDP- sis lose their virulence and can be cleared by the immune
system [5]. The widespread distribution of L-rhamnoseD-glucose to dTDP-L-rhamnose in an NAD(P)H- and
Mg2-dependent reaction. L-rhamnose biosynthesis is and its relevance for several clinically important patho-
gens, together with the fact that mammals neither pro-an antibacterial target. The structure of RmlD from
Salmonella enterica serovar Typhimurium has been duce nor utilize L-rhamnose, makes its biosynthesis a
valid target for novel therapeutic compounds.determined, and complexes with NADH, NADPH, and
dTDP-L-rhamnose are reported. RmlD differs from The generation of the L-rhamnose scaffold requires
four enzymatic steps starting from glucose-1-phos-other short chain dehydrogenases in that it has a novel
dimer interface that contains Mg2. Enzyme catalysis phate and ending in dTDP-L-rhamnose (Figure 1). The
pathway has been known for over forty years [6, 7], butinvolves hydride transfer from the nicotinamide ring
of the cofactor to the C4-carbonyl group of the sub- only recently have thorough structural descriptions of
the first three enzymes involved in dTDP-L-rhamnosestrate. The substrate is activated through protonation
by a conserved tyrosine. NAD(P)H is bound in a sol- synthesis been published [8–12]. RmlA is a glucose-1-
phosphate thymidylyltransferase likely to be feedbackvent-exposed cleft, allowing facile replacement. We
suggest a novel role for the conserved serine/threo- controlled by dTDP-L-rhamnose [13]. RmlB, a dTDP-D-
glucose 4,6-dehydratase, has recently been subjectednine residue of the catalytic triad of SDR enzymes.
to extensive mechanistic investigation. Epimerization at
positions 3 and 5 is carried out by dTDP-6-deoxy-D-Introduction
xylo-4-hexulose 3,5-epimerase (RmlC), an interesting
enzyme that does not require any cofactor to achieveInfectious microorganisms pose a permanent threat to
the health of higher animals, such as livestock and man. this transformation.
We describe here the structure of RmlD from Salmo-The development of antibiotics, starting with the discov-
ery of penicillin, equipped us with an arsenal of powerful nella enterica serovar Typhimurium, which is one of the
Salmonella species that cause foodborne infections.weapons to combat diseases resulting from bacterial
infections. However, the use and abuse of antibiotics RmlD has only recently been shown to exist as an
independent enzyme from the 3,5-epimerizing activitieshave lead to the rise of resistant strains, in some cases
in the pathway, carrying out only the final reduction
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Figure 1. The Rhamnose Pathway
RmlD catalyzes the final step, the reduction of dTDP-L-rhamnose.
Oxidation at position 4 in a preceding RmlB-mediated Results and Discussion
step activates the initial glucose structure for subse-
quent reactions at positions 3, 5, and 6 by acidifying The Monomer Consists of Two Domains
The structure was determined by multiwavelengththe hydrogen atoms at positions 3 and 5 vicinal to the
4-carbonyl group. By reducing this carbonyl group, anomalous diffraction (Table 1). The complexes were
determined by molecular replacement using the nativeRmlD eliminates the activity of its substrate, which is
otherwise unstable [14], and locks the carbohydrate in structure (Table 2). The RmlD chain folds into a bean-
shaped structure with approximate diameters of 63 A˚ the L-rhamnose conformation.
RmlD contains a catalytic triad consisting of a threo- 51 A˚ 44 A˚ (Figure 2A). The monomer can be subdivided
into two domains of different function, but, as neithernine residue and a conserved YXXXK sequence. This
pattern, together with the so-called Wierenga motif is composed from a consecutive stretch of amino acids,
they cannot be treated as separate folding units. On(GXXGXXG) in a Rossmann-type fold [15], identifies
RmlD as a member of the reductases/epimerases/dehy- the basis of backbone-backbone hydrogen bonds, we
assign residues Met1 to Tyr155, Tyr183 to Thr221, anddrogenases (RED) enzyme superfamily [16], where it is
located in the short chain dehydrogenase/reductase Gly262 to Trp282 as the larger N-terminal domain. It
contains all residues that interact with the cofactor(SDR) branch [17]. A large number of structures and a
wealth of detail about the general mechanism that these NAD(P)H and is hence denoted as cofactor binding do-
main. This part of the structure is dominated by the well-enzymes follow have been revealed in recent years [18].
SDR enzymes bind a wide variety of substrates, includ- known Rossmann fold. In the case of RmlD, this features
a six-stranded parallel  sheet, in the order 213456,ing carbohydrates, steroids, prostaglandins, alcohols, and
other small molecules, e.g., dihydropteridines, on which sandwiched between a layer of  helices. Many related
structures, including RmlB [9], have an additional /they can carry out a variety of reactions, such as reduc-
tions, oxidations, epimerizations, or dehydratations. element inserted after strand 2. The N-terminal loop of
this element closes over the NAD(H) molecule and, atThey require NAD(H) or NADP(H) as their cofactor and
normally show a preference for one over the other. RmlD the same time, restricts the size of the cofactor binding
site. As a consequence these proteins cannot utilizeis slightly unusual in this respect, because it does not
show strong preference for either cofactor. Moreover, NADPH. The additional loop also leads to a tight binding
of the cofactor. A feature that RmlD shares with mostRmlD requires Mg2 for full activity, an observation that
cannot be explained from the general mechanism postu- other SDR enzymes is a kink in  helix 4, with one resi-
due, usually an asparagine or aspartate (Asn81 in RmlD),lated for other relatives of the SDR branch [14].
As a drug target RmlD could be the most appealing bulging out of a helical turn. This residue is not involved
in substrate turnover but forms a hydrogen bond withenzyme in the L-rhamnose pathway, as it can be expected
to have the most specific binding pocket for L-rhamnose- the side chain of Thr131, which is one of the residues
located in the middle of the mechanistically importantlike compounds, which do not exist in mammals.
Our work establishes the role of Mg2 in stabilizing YXXXK motif. Asn81 also makes two hydrogen bonds
with the backbone nitrogen atom and carbonyl groupthe dimer interface. It shows how both NADH and
NADPH are recognized, and it locates the substrate of His64. His64 lies in a loop (Ala61–Ala66) that otherwise
forms no hydrogen bonds to the protein core but repre-binding site. The identification of key catalytic residues
from the structural data was tested by site-directed mu- sents one-half of a clamp binding the nucleotide moiety
of the cofactor.tagenesis.
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Table 1. Structure Determination
Data Collection MAD (ESRF BM14)
Wavelength (A˚) 0.9790 (peak) 0.9791 (inflection) 0.8856 (remote)
Resolution (highest shell, A˚) 28.7–2.40 (2.47–2.40) 28.7–2.40 (2.46–2.40) 28.7–2.25 (2.31–2.25)
Space group P21212
Cell constants (A˚; ) a  47.5, b  72.1, c  82.6;       90
VM 2.17
Unique reflections 9,621 9,612 12,636
Average redundancy 3.6 (2.1) 3.6 (2.0) 3.7 (2.2)
I/ 10.6 (1.3) 14.3 (1.4) 8.9 (1.2)
Completeness (%) 88.5 (40.0) 97.0 (71.5) 99.3 (94.6)
Anomalous completeness (%)a 85.7 (51.4) 88.4 (39.7) 94.1 (50.1)
Rmergeb 3.4 (52.6) 3.3 (52.1) 4.0 (61.7)
f	/f″ 
6.2/6.0 
10.2/3.1 
1.3/3.2
a Anomalous completeness corresponds to the fraction of possible acentric reflections for which an anomalous difference has been measured.
b Rmerge  I(h)i 
 I(h)/I(h)i, where I(h)i is the measured diffraction intensity and the summation includes all observations.
The second domain in RmlD is involved in substrate are exclusively hydrophilic and generate a metal binding
site that holds a hexa-hydrated Mg2 ion in our structurebinding and includes amino acids Ala156–Gln182,
Thr222–Pro261, and Glu283–the C-terminal residue (Figure 2B). Three glutamic acid residues, Glu15, Glu190,
and Glu292, from each monomer are within strong hy-Ile299. Of these positions, amino acids Gln174–Ile179
and Ile239–Ala258 are extremely flexible and could only drogen bonding distance from the water molecules sur-
rounding the metal ion, at an average distance of 2.1 A˚. Awith great difficulty be built into the electron density.
The substrate binding domain contains a deep cleft, second coordination sphere of positively charged amino
acids, namely, Arg18 and Arg288, compensates for thiswhich is generated from a bundle of three  helices on
the side proximal to the second monomer and a double- accumulation of negative charges. The guanidinium
head group of Arg18 forms an additional salt bridge withstranded parallel  sheet structure on the opposite. This
cleft enables the enzyme to accommodate sugar nucle- Asp194, and N from the side chain of Trp14 contributes
to the formation of another hydrogen bond with Glu292.otides in an outstretched conformation. The active cen-
ter of RmlD is located where the two binding groves The complexity of this interaction network, the high de-
gree of conservation of the mentioned amino acids inpoint toward each other.
RmlD sequences from other organisms, and the ob-
served magnesium dependency of RmlD collectively ar-RmlD Has a Novel Mg2-Dependent
Dimerization Mode gue strongly that this dimer represents the physiologi-
cally active form of RmlD and is not a crystallizationThe vast majority of members of the SDR family structur-
ally characterized so far are either dimers or multiples artifact. The dimer interface covers10% of the acces-
sible surface of the monomer. This relatively small valueof dimers, e.g., RmlB [9] or the tetrameric 3,20-
hydroxysteroid dehydrogenase [19]. Exceptions exist in and the fact that most residues buried in the interface
are hydrophilic show that the driving force for dimeriza-ADP-L-glycero-D-mannoheptose 6-epimerase, which is
a homopentamer [20], and in the very recently published tion has to stem from magnesium binding. It is, however,
not immediately clear why the metal ion is required formonomeric enzymes porcine carbonyl reductase [21]
and human biliverdin IX reductase [22]. The dimers full activity [14], as the two active centers of the dimer
are structurally independent from each other, and, inidentified to date, with the exception of 3-hydroxy-
steroid dehydrogenase/carbonyl reductase from Coma- principle, activity should not depend on dimerization.
Dimerization could be essential for proper positioning ofmonas testosteroni [23], which has a different and
unique arrangement, all interact through  helices 3 and the cofactor binding domain and the substrate binding
domain toward each other within a monomer. This could4 of the cofactor binding domain, corresponding to heli-
ces 4 and 5 in RmlD (Figure 3B). This generates a four- be mediated by the residues that participate in genera-
tion of the Mg2 binding site or through monomer/mono-helix bundle with a monomer/monomer interface that
has mainly hydrophobic character and that lets the two mer interaction in other parts of the interface, e.g., the
contacts between the C-terminal helix C from the sub-active centers lie at opposite positions of the dimer
with no interaction between them. The corresponding  strate binding domain of monomer A and helix 1 from
the cofactor binding domain of monomer B. It is clearhelices in RmlD, however, have amphipathic character,
with hydrophilic residues pointing to the location where that, in the absence of Mg2 ions, negatively charged
residues from the cofactor and substrate binding do-the second monomer would normally be located. In con-
trast, the monomer/monomer interaction in this enzyme mains (Glu15, Glu190, and Glu292, respectively) would
accumulate without compensation, and, as a conse-is mainly through  helices 1 and 6 from the cofactor
binding domain and helix C from the substrate binding quence, the relative position of the two domains may
be destabilized.domain (Figure 3A). This places the interface on the
opposite site of the Rossmann fold when compared to It is interesting to note that RmlB and RmlD, which
are related at both the functional and tertiary structuralenzymes such as RmlB.
The contacts found between the two RmlD monomers levels, occur as adjacent genes in the rml operons of
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Figure 2. The Structure of RmlD
(A) The RmlD monomer. Cofactor binding domain, yellow; substrate binding domain, blue. Secondary structure elements are labeled following
the nomenclature used in the text.
(B) The magnesium binding site. Fo 
 Fc electron density for magnesium and the six coordinating water molecules is contoured at 3 . Residues
from the second monomer are colored in gray and marked by an asterisk. The colors in the protein are as follows: carbon atoms, yellow;
nitrogen, blue; oxygen, red.
many bacteria. This could be interpreted as a reflection shaped RmlD monomer (Figures 4A and 5A). The nicotin-
of an ancestral gene duplication event. However, the amide forms an internal hydrogen bond between the
relatively low levels of sequence identity (less than 15%) amide and the -phosphate group to be in a syn confor-
and the different mechanisms of dimerization in the two mation with the B face lying toward the substrate. This
enzymes suggest that this is unlikely. orientation is further stabilized through the side chain
of Val154, which lends a hydrophobic support to the
nicotinamide ring. Lys132 of the conserved YXXXK motifThe Cofactor Binding Site Does Not Discriminate
makes two hydrogen bonds to the 2	- and 3	-hydroxylNADH or NADPH
groups of the adjacent ribose ring. Anchoring of theThe cofactor NAD(P)H adopts an extended conforma-
tion within a cleft on the inside surface of the bean- positive charge of lysine here lowers the pKa value of
Structure
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Figure 3. The RmlD Dimer
(A) The RmlD dimer in complex with NADPH
and dTDP-L-rhamnose. One monomer is col-
ored according to domain organization, as in
Figure 2A, and the other is colored according
to secondary structure ( sheet, green;  he-
lix, cyan); magnesium, orange.
(B) RmlB from Salmonella enterica serovar
Typhimurium. The blue monomer is in the
same orientation as the secondary-structure-
colored (green and cyan) RmlD monomer in
(A). The dimer interface is on the opposite
side of the molecule.
Tyr128 and enables this tyrosine to act as a general makes the interaction between the phosphate bridge
and the protein clamp-like. The ribose moiety of theacid/base in SDR enzyme-catalyzed reactions. O of
Tyr128 forms a short hydrogen bond with the 2	-hydroxyl cofactor’s nucleotide portion is sandwiched between
Ala62 and Ala63 on one side and Gly7 and Gly10 on thegroup.
Binding of the cofactor’s diphosphate group is other. The nearby SDR-conserved Asp30 functions as
a molecular switch to distinguish between NADH andachieved mainly through interaction with the N-terminal
positive pole of  helix 1, which leads to the formation NADPH in RmlD. Its side chain points inward to undergo
a bidentate interaction with the 2	- and 3	-hydroxoof several hydrogen bonds with backbone amide groups
and the side chain of Gln11. This part of the backbone groups of the ribose group in the NADH complex. This is
similar to other SDR enzymes, e.g., RmlB. In the NADPHcontains the characteristic GXXGXXG fingerprint se-
quence in a loop region beginning at the end of  strand complex, in contrast, Asp30 changes its 1 angle by
180 to distance itself from the additional negatively1 preceding  helix 1. A further hydrogen bond to Thr65
Structure and Function of RmlD
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Figure 4. Cofactor Binding Site
(A) The cofactor binding site. Fo 
 Fc electron density for NADH is shown at 3 . The colors in the protein are as follows: carbon atoms, yellow;
nitrogen, blue; oxygen, red. The colors in the cofactor are as follows: carbon, black; nitrogen, blue; oxygen, red; phosphorous, pink.
(B) Residues that interact with the cofactor. NADH, black lines; NADPH, thin gray lines. Note the change in Asp30’s side chain conformation
in response to the phosphate group at O2 of the ribose ring. Atoms are colored as in (A).
charged phosphate group (Figure 4B). Two water mole- exposed and does not interact with any protein residue.
This explains the promiscuity of RmlD with respect tocules take the position of the aspartate side chain in
the NADH complex here. This recognition mechanism cofactor preference and distinguishes RmlD from other
NADPH-utilizing SDR enzymes that have developedis effectively ruled out in SDR enzymes that exclusively
bind NAD(H). In these proteins, the presence of an addi- specific binding pockets for the additional phosphate
group, e.g., porcine carbonyl reductase [21]. Finally, thetional strand in the core  sheet generates a hydropho-
bic pocket that hinders rotation of Asp30 by steric and adenine ring of the cofactor is located in a pocket formed
by residues Val31, Asp39, Phe40, Ala62, Ala63, andelectronic clashes. In addition to the recognition switch,
the ribose ring is tilted by 30 away from Asp30 in the Leu80. The hydrophobic nature of this interaction site is
modified by hydrogen bonds between N1 of the adenineNADPH complex. This is achieved through adjustments
in the torsion angles of the bridge connecting the two group and atom N of Phe40 and between the amine
group at adenine N6 and the negatively charged sidenucleotide groups of the cofactor. As a consequence
the additional phosphate group of NADPH is solvent chain of Asp39.
Structure
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Figure 5. Substrate Binding Site
(A) The substrate binding site. Fo
 Fc electron
density for dTDP-L-rhamnose is shown at 3
. In the substrate, carbon is shown in green.
Other atoms are colored as in Figure 4A.
(B) The residues that interact with dTDP-L-
rhamnose. The position of NAD(P)H in the
noncomplexed structured is indicated in thin
gray lines. Atoms are colored as in (A).
(C) Changes in the overall structure of RmlD
on dTDP-L-rhamnose binding. NADPH, black;
dTDP-L-rhamnose, magenta.
Structure and Function of RmlD
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RmlD catalyzes the reduction of dTDP-6-deoxy-L- Table 3. Enzyme Assay of RmlD and Mutants
lyxo-4-hexulose to yield dTDP-L-rhamnose. As RmlD
Relative Specific
does not rely on a second substrate that regenerates Enzyme Km (mM) Activity
the reduced cofactor, NAD(P) has to be released, and
Wild-Type 0.11  0.02 1  0.1a new cofactor molecule has to be bound to regain
D68A 0.06  0.02 0.1  0.01
enzymatic activity. Consequently, the NAD(P)H binding V67A 0.008  0.003 0.02  0.01
site of RmlD needs to be readily accessible to solvent T104A Activity not detected.
and to only weakly bind cofactor. This behavior is re- Y128F Activity not detected.
W153A Activity not detected.flected in the relatively high cofactor concentrations
(10–20 mM) that were necessary to obtain clear electron
density for this molecule. In other SDR structures, such
the plane of the carbohydrate gets oriented such thatas RmlB, in contrast, NAD is tightly bound in the puri-
its C4	 atom and C4 of the nicotinamide ring lay onlyfied protein. As discussed earlier these proteins possess
3.1 A˚ apart from each other. It is likely that both atomsan additional loop that closes over the nucleotide moi-
approach each other even further in the true reactionety. As a consequence of the lack of space constraints
intermediate, where the hydrogen atoms at C4	 of thedue to the absence of this loop and of the ability to
substrate and at C4 of the nicotinamide do not hinderreplace the specific interaction with Asp30 by a water-
each other. This would, at the same time, lead to amediated hydrogen bonding network, RmlD uses NADH
more perpendicular attacking angle for the transferredand NADPH nearly equally well.
hydride ion onto the sp2-hybridized carbon atom of the
C4	-carbonyl group, which seems ideal for an optimal
orbital overlap. In the abortive dTDP-L-rhamnose/RmlDThe Substrate Binding Site Is an Extended
Solvent-Exposed Pocket complex, this angle is clearly larger than 90. The effect
of the additional hydrogen atom is also evidenced by aWe formed an abortive complex of RmlD with reduced
cofactor NADPH and the product dTDP-L-rhamnose by displacement of the nicotinamide-ribosyl unit of NADPH,
which is pushed further into the cofactor binding onsoaking NADPH-containing crystals in mother liquor
supplemented with 10.6 mM dTDP-L-rhamnose and 4 dTDP-L-rhamnose binding (Figure 5B).
Selectivity for dTDP-L-rhamnose-like ligands and cor-mM DTT. The electron density of this complex is not of
very high quality due to resolution limitations of the data rect stereochemical orientation for hydride transfer are
achieved through various factors. To generate an equa-and high flexibility of the substrate binding domain, es-
pecially in the two areas of Gln174–Asn180 and Ile239– torial hydroxyl group at C4	, D-glucosyl and L-rhamnosyl
carbohydrates have to approach the cofactor with oppo-Arg260 (Figure 5A). It is nevertheless possible to un-
equivocally determine the orientation of the L-rhamnose site faces, as the chiral center at C4	 gets inverted in
the course of dTDP-L-rhamnose synthesis. Binding ofgroup relative to the nicotinamide ring of the cofactor
and to identify key interactions between protein and a D-glucosyl nucleotide in this orientation is not possi-
ble, as these molecules are normally  linked, leadingligand (Figures 5A and 5B). Disorder of the two men-
tioned regions is a feature of many sugar-converting to clashes of their 1	-phosphate group with the side
chains of Val67 and Tyr106. Consequently, RmlD cannotSDR enzymes, e.g., ADP-L-glycero-D-mannoheptose
6-epimerase, where the corresponding residues have turn over the product of RmlB. The importance of the
bulky Tyr106 residue for sugar-plane orientation is high-been omitted from the deposited coordinates [20]. The
two stretches adopt an extended conformation on the lighted by the fact that it is not present in the related
SDR enzyme UDP-galactose 4-epimerase, in which thesurface of the protein with  sheet-like interactions be-
tween them and little contact with the protein core. They carbohydrate ring has to present both faces to the co-
factor and thus undergoes a 180 rotation in the coursefunction as a binding site for the nucleotide moiety of
the ligand through backbone-base hydrogen bonds and of its epimerization [26]. RmlD achieves selectivity for
6-deoxysugars through the generation of a hydrophobicoften through additional stacking interactions with an
aromatic side chain. It should be noted that this part of pocket that is built with the hydrophobic parts of the
side chains of Thr65, Tyr106, Tyr128, and Val67, togetherthe structure varies between enzymes carrying out the
same function in different organisms e.g., the RmlB pro- with the nicotinamide ring of the cofactor. This pocket
forms around the methyl group of the L-rhamnose moi-teins from E. coli, Salmonella enterica serovar Typhimu-
rium [9], or Streptococcus suis [24]. This shows that ety and would clearly not be optimally suited to accom-
modate the hydroxyl group of a D-glucose ring. Mutationabsolute conservation of these flexible parts is not man-
datory for activity and substrate specificity. The sugar of Val67 significantly reduces enzyme activity (Table 3).
The remainder of the carbohydrate binding site is morenucleotide molecules are flexible enough to account for
changes in their binding sites. hydrophilic. This asymmetry leads to the correct orienta-
tion for hydride transfer and generates more discriminat-The substrate binding pocket of RmlD lies in a solvent-
exposed groove that extends from the cofactor binding ing factors for the selection of L-rhamnosyl ligands
through hydrogen bonds. The axial 2	-hydroxyl group ofsite into the C-terminal domain. dTDP-L-rhamnose is
bound with its carbohydrate ring sandwiched between L-rhamnose interacts with the oxygen of the cofactor’s
carboxamide group and a water molecule that is partthe carboxamide group of the cofactor and the aromatic
ring of Tyr106, which acts as a hydrophobic support. of a network linked to nearby protein residues. The equa-
torial O3	 accepts a proton from the backbone N atomSimilar stacking of an aromatic residue and a carbohy-
drate ring is well known from lectins [25]. In this way of Trp153 and donates another to the side chain of
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Asp105. Mutation of Trp153 eliminates detectable activ-
ity. The oxygen atom that needs to be protonated in the
course of the reaction, O4	, is within direct hydrogen
bonding distance of Thr104 but not Tyr128 in our com-
plex. However, only small changes are necessary to
establish an interaction with Tyr128. The absence of
this important hydrogen bond is probably due to the
additional hydrogen atom in this abortive complex, pre-
venting true positioning of the ligand.
A binding interaction for the ligand’s negatively
charged diphosphate bridge is provided by the guanidi-
nium group Arg260. Similar interactions are observed
in other structures of sugar nucleotide-converting SDR
enzymes, but the absolute position of the arginine resi-
due is not conserved. The 2	-deoxyribose moiety is not
in direct contact with any protein residue, and the thymi-
dine group is within hydrogen bonding distance from
the backbone atoms of residues Ala177–Ile179, which is
reminiscent of related SDR enzymes. Residual electron
density indicates a stacking interaction with Tyr254.
This, however, requires the protein backbone around
Figure 6. The Reaction Mechanism of RmlDthis residue to change slightly, and the electron density
is not clear enough to assign the required adjustments Distances refer to separation of nonhydrogen atoms.
unambiguously.
unclear. Initially, it was suggested that this residue acts
as a proton shuttle, as the distance between tyrosineRmlD Catalyzes the Simplest Reaction of All
Sugar-Converting SDR Enzymes and the substrate in abortive complexes has been found
too large to allow direct proton exchange between theThe sugar-converting enzymes whose structures have
been elucidated to date all carry out reactions that ex- two groups [26]. However, these abortive complexes
might not adequately represent the situation in true reac-tend beyond a simple hydride transfer to or from the
cofactor. For example, in addition to their C4	-oxidizing tion intermediates, where substrate and tyrosine can
approach each other more closely due to the absence offunction, RmlB and GDP-mannose 4,6-dehydratase [27]
simultaneously dehydrate their substrate. The related an additional hydrogen atom. As an additional argument
against the proposed shuttle mechanism, the distance4-epimerases carry out an oxidation first, before they
reduce the reoriented ligand. SDR enzymes that addi- between tyrosine and serine/threonine in all published
complexes is too long for the required hydrogen bondtionally catalyze a 3,5-epimerization, e.g., GDP-fucose
synthetase [28], require additional residues to react with between the two residues. In the dTDP-L-rhamnose
complex presented in this study, the distances are 4.3 A˚the substrate. These proteins abstract and redonate
protons to the carbonyl-activated positions 3 and 5 of between the hydroxyl groups of Tyr128 and Thr104 and
3.9 A˚ and 2.8 A˚ from Tyr128 O and Thr104 O to thethe carbohydrate ring. As RmlD only carries out a hy-
dride transfer to position 4, this enzyme is very well substrate’s 4	-hydroxyl group, respectively. An increas-
ing body of experimental data now suggests a directsuited to determine key factors for the basic reaction
of sugar-converting SDR enzymes. proton exchange between tyrosine and the substrate
[24, 30–32]. A short hydrogen bond of 2.5 A˚ betweenImportant residues for hydride transfer are tyrosine
(Tyr128) and lysine (Lys132) of the YXXXK motif, as well tyrosine and the substrate is indeed observed in non-
abortive complexes of S. suis RmlB with dTDP-xyloseas Thr104, which is often found as a serine residue in
related enzymes, such as UDP-galactose 4-epimerase. [24] or the sulfolipid biosynthesis protein SQD1 from
Arabidopsis thaliana with UDP-glucose [32]. This wouldThis catalytic triad acts to activate the substrate’s car-
bonyl or hydroxyl group through protonation or deproto- indicate that a low-barrier hydrogen bond (LBHB) is
formed between these groups in the transition state ofnation, respectively (Figure 6), and mutation of Tyr128
or Thr104 effectively removes catalytic activity of RmlD the general SDR enzyme mechanism. In a low-barrier
hydrogen bond, the two participating centers share a(600-fold reduction). The general acid/base in this
mechanism is the conserved tyrosine, whose O pKa proton with partial covalent character rather than inter-
acting only by electrostatic means. As a consequence,value has been lowered to a value below 7 by the pres-
ence of the positively charged lysine residue and the no energy is required to shift the proton from one partici-
pating group to the other [33]. A low-barrier hydrogenemerging/existing positive charge on the nicotinamide
ring [29, 30]. Lys132 does not interact with tyrosine di- bond between tyrosine and the substrate would greatly
facilitate the reactions brought about by SDR enzymes,rectly but is strongly hydrogen bound to the ribosyl unit
of the cofactor. The conserved serine/threonine residue as it removes the high-energy barrier that normally pre-
vents the protonation of a carbonyl group (pKa valuewas found to be involved in short hydrogen bonds with
the carbonyl/hydroxyl group of the substrate in ternary ca. 
7) or the deprotonation of a hydroxyl group (pKa
value ca. 16). At the same time this would explain whycomplexes of SDR enzymes, but its exact role remains
Structure and Function of RmlD
783
SDR enzymes can catalyze oxidation and reduction re- binding site with a maximum displacement of 3.0 A˚ at
Gly159 relative to the NADPH complex. The movementactions equally well.
The observation that tyrosine acts as the acid directly of this helix will also be responsible for the slight overall
shift of the substrate binding domain. The quality of theraises the questions concerning the need of a conserved
Ser/Thr residue. This amino acid is often found involved data does not reveal whether the changes in the substrate
binding domain are accompanied with the generationin short hydrogen bonds of 2.5 A˚ with the substrate,
and Thoden et al. have recently described this as a low- of a new hydrogen bonding pattern in the protein, but
it is clear that the GKGN loop at positions 157–160,barrier hydrogen bond in human UDP-galactose
4-epimerase [30]. In this enzyme the substrate has to which precedes  helix A, acts as a hinge, changing
its backboneφ/ angles on dTDP-L-rhamnose binding.be oxidized and, therefore, deprotonated in the first step
of catalysis. According to these authors, formation of The domain movement might be larger in solution, where
it is not hindered by crystal contacts.an LBHB between a 4	-hydroxylate and the serine/threo-
nine residue could provide enough energy to enable the
otherwise unfavorable deprotonation of the 4	-hydroxyl Biological Implications
group and thus drive the reaction. However, this only
explains proton abstraction in an oxidation of the sub- The threat imposed by infectious microorganisms gen-
strate. It does not accommodate the opposite case of erates a permanent need for the development of novel
reduction with concomitant substrate protonation (the antibiotics. The biosynthesis of L-rhamnose, a 6-deoxy-
reaction catalyzed by RmlD). We therefore propose that hexose not found in mammals, presents itself as an
the serine/threonine residue fulfils a more general role interesting drug target. Among the four proteins in this
in an SDR mechanism proceeding through an LBHB pathway, the last enzyme, RmlD, a member of the short
between the catalytic tyrosine and the substrate. To chain dehydrogenase/reductase family, is possibly the
form an LBHB it is crucial that the pKa values of the best candidate for the development of new drugs, as
participating groups are matched; otherwise, the proton it can be expected to show the highest specificity for
cannot be shared. The pKa value of tyrosine in SDR L-rhamnose-like ligands.
enzymes is below 7, and that of the substrate is either
7 RmlD is the first representative of a new Mg2-depen-
or 16, depending on whether a carbonyl group is re- dent dimerization mode of the SDR enzymes. This ob-
duced or a hydroxyl group is oxidized. Consequently, it servation raises the question whether RmlB and RmlD,
would not normally be possible to transfer a proton from who are neighbors on the gene cluster encoding the
or to the substrate with tyrosine acting as an acid or L-rhamnose pathway enzymes, e.g., in Salmonella spe-
base. However, these values are not necessarily impor- cies, arose through a gene duplication or recombination
tant because it is the pKa value of the transition state event. RmlD follows a typical SDR enzyme mechanism
that will determine the efficiency of LBHB generation and might, due to its simplicity, be the best candidate
and, therefore, catalysis. This pKa value can be expected for studying general principles in SDR enzyme catalysis,
to lie between the two extremes of a carbonyl and a e.g., the more and more acknowledged principle of low-
hydroxyl group. Any hydrogen bond to the intermediate barrier hydrogen bonds in proton transfer mechanisms.
will modify this pKa value, and serine/threonine might Our results show how selectivity for L-rhamnosyl ligands
thus provide fine-tuning to achieve optimal pKa match- is generated in RmlD. This should prove useful in struc-
ing between tyrosine and substrate. As reduction and ture-based inhibitor design. However, the fact that the
oxidation proceed through the same reaction intermedi- ligand binding sites of RmlD are extremely solvent ex-
ate, the presence of this side chain then enables both posed could hamper the development of high-affinity
processes equally well. It would be interesting to investi- molecules.
gate the hydrogen distribution in the active center of
a complexed SDR enzyme through neutron diffraction Experimental Procedures
studies. However, the intrinsic quality of the available
Protein Purification and CrystallizationRmlD crystals currently precludes such experiments.
Recombinant native RmlD from Salmonella enterica serovar Typhi-Other events would have to accompany the proton
murium was overexpressed in Escherichia coli strains BL21(DE3)
transfer in RmlD should it follow the proposed route. and BL21(DE3) pLysS cells and purified as described previously
For example, the substrate has to approach Tyr128 [34]. Selenomethionine labeling was achieved by the method of
much more closely than it does in the abortive RmlD/ Budisa et al., using the methionine-auxotroph E. coli strain
B834(DE3) as the expression host [35]. Plate-shaped crystals weredTDP-L-rhamnose complex, where the additional hy-
initially obtained in the presence of 4 mM DTT and 2.5 mM NADPHdrogen atom hinders a closer contact. At the same time,
from 22% (w/v) PEG 4000, 0.1 M HEPES (pH 7.1), and 0.2 M MgCl2Tyr128 has to stay in its hydrogen bonding network in
with the sitting drop vapor diffusion method [36]. As it became
order not to raise its pKa value, thereby losing its ability obvious that Mg2 ions are required for dimerization, screens for
to act as a proton donor. The required changes will new crystallization conditions were carried out with protein that had
therefore be achieved through movements of or within been dialyzed against 50 mM Tris-HCl (pH 7.5) and 100 mM MgCl2.
Crystals with a more three-dimensional appearance were obtainedthe ligand binding domain, as has been observed in
by shifting the crystallization conditions slightly to 22%–24% (w/v)human UDP-galactose 4-epimerase [30]. In RmlD, the
PEG 4000, 10% (v/v) isopropanol, and 0.1 M HEPES (pH 8.0) (aposubstrate binding domain moves on dTDP-L-rhamnose
and NADPH data sets) or 24% (w/v) PEG 4000, 0.2 M MgCl2, andbinding as well, but it is only accompanied with a very
0.1 M Tris-HCl (pH 8.5) (NADH data set). All crystals belonged to
slight closure of the substrate binding pocket. The most space group P21212, with approximate cell constants of 47.5, 72.1,
significant changes take place at helix A of the cofactor and 82.6 A˚ and       90, indicative of one RmlD monomer
in the asymmetric unit. It became clear from the electron densitybinding domain, which gets shifted toward the cofactor
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that 2.5 mM of NADPH would not be sufficient to saturate the cofac- by nucleotide sequencing using the Sequenase 2.0 protocol (Amer-
sham Pharmacia Biotech) and an ABI 377 automated DNA se-tor binding site. Therefore, the protein was either incubated with 20
mM cofactor (NADPH data set) prior to crystallization setup or crys- quencer (Applied Biosystems). The mutant proteins were expressed
in E. coli BL21(DE3) pLysS cells and purified in the two-step proce-tals were soaked overnight in mother liquor containing 20 mM NADH
(NADH data set). An RmlD/NADPH/dTDP-L-rhamnose complex was dure described previously [34]. However, we were unable to achieve
expression of S103A and D105A.obtained by overnight soaking of a plate-shaped crystal in mother
liquor containing 10.6 mM dTDP-L-rhamnose, which had been pre-
pared following the method of Graninger [14]. Enzymatic Activity
Kinetic assay of wild-type and mutant RmlD proteins was carried
Data Collection out using 20 mM Tris-HCl (pH 6.5), 10 mM MgCl2, 0.072 mM NADPH,
MAD data from selenomethionine-labeled crystals grown under the and 1.47 pM RmlD. RmlB and RmlC were added in 24-fold molar
initial crystallization conditions were presented in a previous report excess relative to RmlD. D68A and V67A had to be used at 2- and
[34]. These data were collected on BM14 of the ESRF (Grenoble, 6-fold-higher concentration to obtain measurable reaction rates.
France) and were only used at initial stages of the refinement until RmlD was determined to be the rate-limiting factor upon the obser-
higher resolution data sets revealing more detail about ligand bind- vation that doubling the amount of RmlD doubled the reaction rate.
ing became available. All native data sets presented here have been Similarly, halving the amount of RmlD caused the reaction rate to
collected on beamlines ID14EH1/2 (apo, NADH, and NADPH/dTDP- decrease by half. dTDP-D-glucose was added at concentrations
L-rhamnose complexes) of the ESRF (Grenoble, France) and at sta- between 0.025 mM and 1 mM to calculate Michaelis-Menten param-
tion 9.6 of the SRS (Daresbury, UK; NADPH complex) using Quantum eters. The consumption of NADPH was measured by the change in
ADSC CCD detectors. Cryoprotection was, in all cases, achieved absorbance at 340 nm using a Helios  Scanning Spectrophotome-
by soaking crystals in mother liquor supplied with with 15% (v/v) ter and VISION software (UNICAM). Background absorbance, deter-
PEG 600 for 45 s prior to flash cooling in the nitrogen stream. MAD mined by setting up the reaction with no RmlD, was subtracted from
and NADPH/dTDP-L-rhamnose complex data were reduced in the measurements. The kinetic parameters Km and Vmax, shown in
DENZO and SCALEPACK [37]; in the remaining cases data were Table 3, were calculated in Graphpad Prism (Graphpad Software).
indexed and integrated in MOSFLM [38] and scaled in SCALA [39].
All crystals showed strong diffuse scatter, and data quality suffers Figures
from serious anisotropy, as indicated by the falloff analysis included Molecular representations were prepared in BOBSCRIPT [47]
in TRUNCATE [39]. Data collection statistics for all data sets men- through the GL_RENDER interface (L. Esser and J. Deisenhofer,
tioned in this article are shown in Tables 1 and 2. unpublished data) and rendered with POV-Ray.
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Accession Numbers
The atomic coordinates and structure factors of all RmlD structures
discussed here have been deposited in the Protein Data Bank [48].
The accession numbers are 1kbz for the apo structure, 1kc0 for the
NADH complex, 1kc1 for the NADPH complex, and 1kc3 for the
NADPH/dTDP-L-rhamnose complex.
